| Gebro Pharma AG - Makatussin Comp., Hustensirup | | 39255 | | 03 | | Makatussin Comp. | | Hustensirup | | R05DA20 | | Kombinationen | | 26.05.2010 | | |
| | Composition | | dihydrocodeini hydrochloridum 10 mg, diphenhydramini hydrochloridum 15 mg, acidum citricum, neohesperidini dihydrochalconum, saccharum 3.9 g, sorbitolum liquidum non cristallisabile 250 mg, aromatica, E 211 3.5 mg, fructuum concentratum, aqua ad solutionem pro 5 ml corresp. natrium 0.55 mg. | | Packungsbestandteile | | Sirop | | | | | | | | Principe actif | Concentr. |
|---|
| Dihydrocodeine Hydrochloride | 10mg / 5ml | | Diphenhydramine Hydrochloride | 15mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Dihydrocodeine Hydrochloride | 10 mg | | Diphenhydramine Hydrochloride | 15 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | Aromatica | | | | E 211 | 3.5mg / 5ml | conserv. | | Fructuum Concentrate | | | | Neohesperidini Dihydrochalconum | | | | Saccharum | 3.9g / 5ml | | | Sorbitolum Liquidum non Cristallisabile | 250mg / 5ml | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 031 | 80 ml | 3.70 | 13.25 | B | LS | Oui |
|
|
